The Suspension of Transanal Total Mesorectal Excision (TaTME) in Norway

A joint presentation by: Evidence Based Reviews in Surgery (EBRS), the Canadian Society of Colon and Rectal Surgeons (CSCRS) and the Canadian Association of General Surgeons (CAGS)

Clinical Reviewers: Dr. Marcus Burnstein, Dr. Carl Brown
Methodology Reviewer: Dr. Erin Kennedy
Moderators: Dr. Jason Park, Dr. Indraneel Datta
Recorded on: May 27, 2020

Session Description

Minimally invasive approaches to rectal cancer surgery are sought to improve the perioperative experience for patients who need this care. However, conventional laparoscopic techniques are very challenging to successfully complete, particularly in obese patients with narrow pelvises. Transanal Total Mesorectal Excision (TaTME) was developed in 2011 to help solve this problem and has been promoted through training programs around the globe, often supported by industry sponsors. In this webinar, expert reviewers discuss the study “Transanal total mesorectal excision for rectal cancer has been suspended in Norway” by Wasmuth et al. with a focus on the validity of the study findings, the appropriate use of TaTME in 2020 and broader issues regarding the introduction of new technology.

The methodologic review for this webinar is available HERE via EBRS.

Session Objectives

  • To review the potential benefits of Transanal Total Mesorectal Excision (TaTME) in the treatment of rectal cancer
  • To describe the potential risks associated with TaTME
  • To review critical issues related to the introduction of new technology or techniques into surgical practice
  • To understand key issues in the evaluation of new surgical procedures, including learning curves, challenges in RCT evaluation, and patient autonomy/safety

Questions & Answers from the live webinar

Coming soon!

More about EBRS

Evidence Based Reviews in Surgery (EBRS) was developed to foster critical appraisal skills in practicing surgeons and trainees in order that they may evaluate surgical literature and practice Evidence Based Surgery.  Every month, we conduct a “virtual” journal club, evaluating articles focused on treatment effectiveness, causation, risk factors, prognosis, diagnostic tests and practice guidelines.  At the conclusion of each EBRS module, EBRS members will ideally enhance their knowledge and skills to critically appraise the surgical literature.

CAGS is a proud partner of EBRS.

About the Presenters

Dr. Carl Brown is a colorectal surgeon and clinical professor of surgery at the University of British Columbia. He is a minimally invasive rectal cancer enthusiast and has performed over 500 TEMs and over 100 TaTME procedures.

Dr. Marcus Burnstein trained in General Surgery at the University of Toronto and in Colorectal Surgery at the Lahey Clinic in Boston. Dr. Burnstein is a past program director for the University of Toronto Residency Programs in Colorectal Surgery and General Surgery, past chairman of the Royal College Specialty Committee for Colorectal Surgery, and Past-President of the Canadian Society of Colon and Rectal Surgeons. Dr. Burnstein is an Associate Professor of Surgery at the University of Toronto and has a broad practice in diseases of the colon, rectum and anus at St. Michael’s Hospital.

Dr. Erin Kennedy, MD, PhD is a colorectal surgeon at Mount Sinai Hospital and Professor of Surgery at University of Toronto. Dr Kennedy’ s clinical and research interests are in rectal cancer and she leads a clinical research program focusing on quality improvement in rectal cancer care.

Dr. Indraneel Datta, MD, MSc (HEPM), FRCSC is a Colon & Rectal Surgeon at Peter Lougheed Hospital and an Clinical Associate Professor in the Departments of Surgery and Oncology at the Cumming School of Medicine, University of Calgary.

Dr. Datta’s primary academic focus has been in health policy and general, colon and rectal surgery. He was the recipient of the 2011 Sir Brian Abel Smith Prize in Social Policy at LSE and for the past 5 years has been the Program Director for the General Surgery Residency Program at the University of Calgary.

Dr. Jason Park, MD, MEd, FRCSC, FACS, is a Surgical Oncologist at St. Boniface Hospital and an Associate Professor in the Department of Surgery at the University Manitoba in Winnipeg, Manitoba.

He serves an Expert Clinical Advisor to the Canadian Institute for Health Information (CIHI), Associate Editor for the Canadian Journal of Surgery, Assistant Chair of the Royal College of Physicians and Surgeons of Canada (RCPSC) Surgical Oncology Exam Committee, and President Elect of the Canadian Society for Surgical Oncology (CSSO).